Fact CheckerSign in

NCT07639619Not yet recruiting

Robot Assisted Minimally Invasive Treatment Versus Conventional Surgery for FFP3-4 Fragility Fractures of the Pelvis in Elderly Patients

Comparing the Efficacy and Safety of Robot Assisted Minimally Invasive Treatment Versus Conventional Surgery in Elderly Patients With FFP3-4 Fragility Fractures of the Pelvis

Source: ClinicalTrials.gov · Last updated 10 Jun 2026

Brief summary (registry, in English)

This prospective randomized controlled trial aims to compare the efficacy and safety of robot assisted minimally invasive treatment versus conventional surgery in elderly patients with FFP3-4 fragility fractures of the pelvis. Eligible patients will be stratified according to FFP classification and randomly assigned in a 1:1 ratio to receive either robot assisted minimally invasive fixation or conventional surgical treatment. Primary and secondary outcomes include pain relief, early mobilization, functional recovery, perioperative complications, venous thromboembolism events, laboratory parameters, imaging outcomes, and healthcare resource utilization. The study aims to provide evidence for optimizing surgical treatment strategies in elderly patients with unstable pelvic fragility fractures.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
88 (estimated)
First submitted
24 May 2026
Start date
1 Jun 2026
Primary completion date
1 Jun 2027
Lead sponsor
Junbo Liang
Diseases
Osteoporosis
NCT number
NCT07639619

What you commit to

  • Study type: Interventional
  • Planned participants: 88
  • From 1 Jun 2026 to the primary completion date, 1 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Hemodynamic instability preventing anesthesia or surgery
  • Current chemotherapy, radiotherapy, systemic corticosteroid therapy, or growth factor therapy

Other illness

  • Severe open injury or skin infection at the surgical site
  • Severe psychiatric disorders or dementia
  • Severe systemic diseases preventing surgery

Other

  • Severe obesity affecting imaging quality
  • Pathological fracture

Who the study is looking for

  • Age ≥ 60 years
  • Low energy trauma
  • Diagnosis of osteoporosis
  • Diagnosis of FFP3 or FFP4 fragility fractures of the pelvis
  • Injury duration less than 3 weeks
  • Ability to provide written informed consent

Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
No. 150 Ximen Road
Coordinator of this site? Confirm its status
LinhaiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.